Zylet

Bausch & Lomb Incorporated🇺🇸 United States

FDA Page

Effective Date: Apr 30, 2022
Approval ID: 3dd9b060-5355-404d-bdf1-09ee8b52a9f5
Products: 1 registered
Version: 18

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ZYLET safely and effectively. See full prescribing information for ZYLET.ZYLET (loteprednol etabonate and tobramycin ophthalmic suspension) 0.5%/0.3%, for topical ophthalmic use Initial U.S. Approval: 2004

Quick Stats

Total Products1

Labelers2

Label Sections13

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.